100 related articles for article (PubMed ID: 34526302)
21. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity for Kras
Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P
Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996
[TBL] [Abstract][Full Text] [Related]
23. Identification of a robust functional subpathway signature for pancreatic ductal adenocarcinoma by comprehensive and integrated analyses.
Wang P; Zhang C; Li W; Zhai B; Jiang X; Reddy S; Jiang H; Sun X
Cell Commun Signal; 2020 Mar; 18(1):34. PubMed ID: 32122386
[TBL] [Abstract][Full Text] [Related]
24. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
Stolzenberg-Solomon R; Derkach A; Moore S; Weinstein SJ; Albanes D; Sampson J
Gut; 2020 Nov; 69(11):2008-2015. PubMed ID: 32060129
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer.
Humpton TJ; Alagesan B; DeNicola GM; Lu D; Yordanov GN; Leonhardt CS; Yao MA; Alagesan P; Zaatari MN; Park Y; Skepper JN; Macleod KF; Perez-Mancera PA; Murphy MP; Evan GI; Vousden KH; Tuveson DA
Cancer Discov; 2019 Sep; 9(9):1268-1287. PubMed ID: 31263025
[TBL] [Abstract][Full Text] [Related]
26. GEO data mining and TCGA analysis reveal altered branched chain amino acid metabolism in pancreatic cancer patients.
Li JY; Sun F; Yang CL; Zhou HF; Gao M; Zhang Q; Chen H; Zhou P; Xiao J; Fan H
Aging (Albany NY); 2021 Apr; 13(8):11907-11918. PubMed ID: 33882453
[TBL] [Abstract][Full Text] [Related]
27. FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis.
Chattaragada MS; Riganti C; Sassoe M; Principe M; Santamorena MM; Roux C; Curcio C; Evangelista A; Allavena P; Salvia R; Rusev B; Scarpa A; Cappello P; Novelli F
Oncogene; 2018 Feb; 37(6):697-709. PubMed ID: 29059164
[TBL] [Abstract][Full Text] [Related]
28. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients.
Li B; Zhang C; Wang J; Zhang M; Liu C; Chen Z
Mol Genet Genomic Med; 2020 Jun; 8(6):e1226. PubMed ID: 32243098
[TBL] [Abstract][Full Text] [Related]
29. V-MitoSNP: visualization of human mitochondrial SNPs.
Chuang LY; Yang CH; Cheng YH; Gu DL; Chang PL; Tsui KH; Chang HW
BMC Bioinformatics; 2006 Aug; 7():379. PubMed ID: 16907992
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma.
Dobre M; Herlea V; Vlăduţ C; Ciocîrlan M; Balaban VD; Constantinescu G; Diculescu M; Milanesi E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440625
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
[TBL] [Abstract][Full Text] [Related]
32. Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.
Liu L; Qi Y; Huang D; Xu Y; Li M; Hong Z; Gu Y; Jia B; Luo X; Zhang S; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195850
[TBL] [Abstract][Full Text] [Related]
33. Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.
Carozzo A; Yaneff A; Gómez N; Di Siervi N; Sahores A; Diez F; Attorresi AI; Rodríguez-González Á; Monczor F; Fernández N; Abba M; Shayo C; Davio C
Mol Pharmacol; 2019 Jul; 96(1):13-25. PubMed ID: 31043460
[TBL] [Abstract][Full Text] [Related]
34. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
Jeong SM; Hwang S; Park K; Yang S; Seong RH
Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
[TBL] [Abstract][Full Text] [Related]
35. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
Cote GA; Gore AJ; McElyea SD; Heathers LE; Xu H; Sherman S; Korc M
Am J Gastroenterol; 2014 Dec; 109(12):1942-52. PubMed ID: 25350767
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer.
Zhu LL; Wu Z; Li RK; Xing X; Jiang YS; Li J; Wang YH; Hu LP; Wang X; Qin WT; Sun YW; Zhang ZG; Yang Q; Jiang SH
Int J Biol Sci; 2021; 17(1):107-118. PubMed ID: 33390837
[TBL] [Abstract][Full Text] [Related]
37. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
Michael Traeger M; Rehkaemper J; Ullerich H; Steinestel K; Wardelmann E; Senninger N; Abdallah Dhayat S
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2419-2431. PubMed ID: 30244390
[TBL] [Abstract][Full Text] [Related]
38. SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
Nweke EE; Naicker P; Aron S; Stoychev S; Devar J; Tabb DL; Omoshoro-Jones J; Smith M; Candy G
PLoS One; 2020; 15(10):e0240453. PubMed ID: 33048956
[TBL] [Abstract][Full Text] [Related]
39. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
[TBL] [Abstract][Full Text] [Related]
40. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y
Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
